Schnoll SH - Search Results

1

Do prescription monitoring programs impact state trends in opioid abuse/misuse?

Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, Dart RC, Bucher Bartelson B. Reifler LM, et al. Among authors: schnoll sh. Pain Med. 2012 Mar;13(3):434-42. doi: 10.1111/j.1526-4637.2012.01327.x. Epub 2012 Feb 2. Pain Med. 2012. PMID: 22299725

2

The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).

Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Muñoz A. Cicero TJ, et al. Pain Med. 2007 Mar;8(2):157-70. doi: 10.1111/j.1526-4637.2006.00259.x. Pain Med. 2007. PMID: 17305687

3

Do abuse deterrent opioid formulations work?

Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Dart RC, et al. Among authors: schnoll sh. J Opioid Manag. 2017 Nov/Dec;13(6):365-378. doi: 10.5055/jom.2017.0415. J Opioid Manag. 2017. PMID: 29308584 Review.

4

Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients.

Cicero TJ, Mendoza M, Cattaneo M, Dart RC, Mardekian J, Polson M, Roland CL, Schnoll SH, Webster LR, Park PW. Cicero TJ, et al. Among authors: schnoll sh. Postgrad Med. 2019 Apr;131(3):225-229. doi: 10.1080/00325481.2019.1585688. Epub 2019 Mar 19. Postgrad Med. 2019. PMID: 30794760

5

Tramadol abuse and dependence among physicians.

Adams EH, Dart RC, Knisely JS, Schnoll SH. Adams EH, et al. Among authors: schnoll sh. JAMA. 2005 Apr 27;293(16):1977; author reply 1977-8. doi: 10.1001/jama.293.16.1977-a. JAMA. 2005. PMID: 15855429 No abstract available.

6

Behavioral economic demand metrics for abuse deterrent and abuse potential quantification.

Schwartz LP, Roma PG, Henningfield JE, Hursh SR, Cone EJ, Buchhalter AR, Fant RV, Schnoll SH. Schwartz LP, et al. Among authors: schnoll sh. Drug Alcohol Depend. 2019 May 1;198:13-20. doi: 10.1016/j.drugalcdep.2019.01.022. Epub 2019 Feb 27. Drug Alcohol Depend. 2019. PMID: 30861390

7

An analysis of the root causes for opioid-related overdose deaths in the United States.

Webster LR, Cochella S, Dasgupta N, Fakata KL, Fine PG, Fishman SM, Grey T, Johnson EM, Lee LK, Passik SD, Peppin J, Porucznik CA, Ray A, Schnoll SH, Stieg RL, Wakeland W. Webster LR, et al. Among authors: schnoll sh. Pain Med. 2011 Jun;12 Suppl 2:S26-35. doi: 10.1111/j.1526-4637.2011.01134.x. Pain Med. 2011. PMID: 21668754

8

Assessment of Amphetamine Withdrawal Symptoms of Lisdexamfetamine Dimesylate Treatment for Adults With Binge-Eating Disorder.

Robertson B, Wu J, Fant RV, Schnoll SH, McElroy SL. Robertson B, et al. Among authors: schnoll sh. Prim Care Companion CNS Disord. 2020 Mar 26;22(2):19m02540. doi: 10.4088/PCC.19m02540. Prim Care Companion CNS Disord. 2020. PMID: 32237290 Free article. Clinical Trial.

9

Challenges in the development of prescription opioid abuse-deterrent formulations.

Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C, Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R. Katz NP, et al. Among authors: schnoll sh. Clin J Pain. 2007 Oct;23(8):648-60. doi: 10.1097/AJP.0b013e318125c5e8. Clin J Pain. 2007. PMID: 17885342 Review.

10

Construct validity and reproducibility of the Prescription Opioid Misuse And Abuse Questionnaire (POMAQ).

Coyne KS, Barsdorf AI, Currie BM, Butler SF, Farrar JT, Mazière JY, Pierson RF, Fisher HJ, Bukhari AA, Schnoll SH. Coyne KS, et al. Among authors: schnoll sh. Curr Med Res Opin. 2021 Mar;37(3):493-503. doi: 10.1080/03007995.2020.1865890. Epub 2021 Jan 18. Curr Med Res Opin. 2021. PMID: 33327799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters